Difference between revisions of "2.16.840.1.113883.10.22.3.1/hgraph"

From HL7 IPS
Jump to: navigation, search
(Automatic ADBot page (a5771e46b7599b36450c3cca02a0674d0ef935ca))
(Automatic ADBot page (a5771e46b7599b36450c3cca02a0674d0ef935ca))
 
Line 46: Line 46:
 
                                         </li>
 
                                         </li>
 
                                         <li class="ad-template">
 
                                         <li class="ad-template">
−
                                             <div class="nowrapinline ad-templatetype cdaentrylevel"> Entry</div> IPS Subordinate SubstanceAdministration (2.16.840.1.113883.10.22.4.33)</li>
+
                                             <div class="nowrapinline ad-templatetype cdaentrylevel"> Entry</div> UV Subordinate Substance Administration (2.16.840.1.113883.10.21.4.6)</li>
 
                                     </ol>
 
                                     </ol>
 
                                 </li>
 
                                 </li>
Line 57: Line 57:
 
             </tr>
 
             </tr>
 
         </table>
 
         </table>
−
<!--b03eb79f2d87245e0873d95e52ab618dc056c336-->
+
<!--e21373183cdc526c35124a4c9de3820eb621e1f0-->

Latest revision as of 05:13, 3 September 2021

  1. Section
     IPS Medication Summary Section (2.16.840.1.113883.10.22.3.1)
    1. Entry
       IPS Body Author (2.16.840.1.113883.10.22.4.14)
      1. Entry
         IPS CDA Device (2.16.840.1.113883.10.22.9.2)
    2. Entry
       CDA Informant (Body) (2.16.840.1.113883.10.12.319)
      1. *
         CDA AssignedEntity (2.16.840.1.113883.10.12.153)
        1. *
           CDA Person (2.16.840.1.113883.10.12.152)
        2. *
           CDA Organization (2.16.840.1.113883.10.12.151)
      2. Entry
         CDA RelatedEntity (2.16.840.1.113883.10.12.316)
        1. *
           CDA Person (2.16.840.1.113883.10.12.152)
    3. Entry
       IPS Medication Statement (2.16.840.1.113883.10.22.4.4)
      1. Entry
         UV Use Period (2.16.840.1.113883.10.21.9.1)
      2. Entry
         IPS Medication Information (detail) (2.16.840.1.113883.10.22.4.2)
        1. Entry
           IPS Manufactured Material (2.16.840.1.113883.10.22.4.3)
      3. Entry
         IPS Body Author (2.16.840.1.113883.10.22.4.14)
        1. Entry
           IPS CDA Device (2.16.840.1.113883.10.22.9.2)
      4. Entry
         UV Subordinate Substance Administration (2.16.840.1.113883.10.21.4.6)
    4. Section
       IPS Translation Section (2.16.840.1.113883.10.22.3.15)
Retrieved from "http://wiki.international-patient-summary.net/index.php?title=2.16.840.1.113883.10.22.3.1/hgraph&oldid=8735"